| Mrs Ann M Golden, | |
|
1730 Lorraine Rd, Reading, PA 19604-1636 | |
| (610) 376-1550 | |
| Not Available |
| Full Name | Mrs Ann M Golden |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1730 Lorraine Rd, Reading, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366762486 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ann M Golden, 1111 Commons Blvd, Po Box 16050, Reading, PA 19605-3334 Ph: (610) 987-8543 | Mrs Ann M Golden, 1730 Lorraine Rd, Reading, PA 19604-1636 Ph: (610) 376-1550 |
News Archive
Increasing access. Improving quality and efficiency. Lowering costs. When GE launched its healthymagination initiative last year, these were the long-term goals and at RSNA 2010, GE Healthcare will highlight a variety of technologies developed to support this strategy and help improve patient care worldwide.
The American Geriatrics Society has published an updated version of the AGS Minimum Geriatrics Competencies for Graduating Medical Students, which were created to ensure that medical school graduates across the U.S. are prepared to provide high-quality care for us all as we age.
Ceridia Pty Ltd., a biotechnology company focused on reformulating and developing therapeutic drugs, announce the successful completion of Phase 1 Proof-of-Concept study of its novel LipoCeramic ibuprofen formulation, CER006.
American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the results of a 12-month single-arm, prospective multi-center study of the Elevate® Apical and Posterior Prolapse Repair System. The pelvic organ prolapse quantification exam (POP-Q), used to quantify, describe, and stage pelvic support, was implemented in the study and concluded efficacy rates of Stage 1 or less to be 89.2% for Apical and 91.7% for Posterior.
› Verified 5 days ago
Brittany Stankovic, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 208 Lincoln Drive, Reading, PA 19606 Phone: 484-408-4744 | |
Miss Nicole Elizabeth Majewski, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1634 W Thistle Dr, Reading, PA 19610 Phone: 610-301-3259 | |
Leanne Liebl, MS, CCC-SLP, TSSLD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24d Congressional Cir, Reading, PA 19607 Phone: 516-946-1280 | |
Keehnkids Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 69-4 Azalea Way, Reading, PA 19606 Phone: 610-401-8572 | |
Maureen A Kennedy, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 421 Chalfont Pl, Apt G421, Reading, PA 19606 Phone: 412-853-9968 | |
Cassidy Quick, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2851 Centre Ave, Reading, PA 19605 Phone: 570-955-6756 | |
Rachel Fegely, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5501 Perkiomen Ave, Reading, PA 19606 Phone: 610-779-0600 |